. Resistant H pylori infections linked to use of antibiotics for COVID-19 - IOPAC Press "Enter" to skip to content

WHO Results Report 2023 shows notable health achievements and calls for concerted drive toward Sustainable Development Goals
- All WHO news
<p>The World Health Organization (WHO) <a href="https://www.who.int/about/accountability/results/who-results-report-2022-2023">Results Report 2023</a>, the most comprehensive to date, showcases achievement of key public health...
Rafah incursion would substantially increase mortality and morbidity and further weaken an already broken health system
- All WHO news
WHO is deeply concerned that a full-scale military operation in Rafah could lead to a bloodbath. More than 1.2 million...
Governments near agreement on package of amendments to the International Health Regulations (2005)
- All WHO news
In the eighth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR), which was suspended yesterday...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Resistant H pylori infections linked to use of antibiotics for COVID-19

By iopac on January 24, 2023

A randomized trial found that antibiotics used to treat Heliobacter pylori infections had lower-than-accepted eradication rates in patients previously treated for COVID-19.

Published in COVID-19

iopac

More from COVID-19More posts in COVID-19 »